| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $24K | -0.9% | +15.2% |
| SG&A Expense | $16K | +15.1% | -0.1% |
| Net Income | -$85K | +6.8% | -0.4% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Total Assets | $478K | +0.7% | -0.3% |
| Current Liabilities | $227K | +52.4% | +158.9% |
| Stockholders' Equity | $250K | -23.0% | -36.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$136K | — | — |
| Investing Cash Flow | -$36K | — | — |
| Financing Cash Flow | $178K | — | — |